Leflunomide
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Leflunomide and local guidelines before prescribing.
Mechanism
Inhibits dihydroorotate dehydrogenase blocking lymphocyte proliferation.
Uses
Rheumatoid arthritis, psoriatic arthritis.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Diarrhoea, hypertension, hepatotoxicity, neutropenia, neuropathy, interstitial lung disease.
Interactions
Methotrexate additive hepatotoxicity; warfarin effect.
Contraindications and cautions
Liver disease, pregnancy
Monitoring
FBC, LFT, BP
Pregnancy and breastfeeding
Contraindicated; wash-out before conception
Renal and hepatic impairment
Contraindicated in severe hepatic impairment
Overdose and reversal
Cholestyramine wash-out
Special advice
Very long half-life; cholestyramine wash-out in toxicity or pregnancy.
More from the textbook: uses, cautions and other points
- Leflunomide | Inhibits dihydroorotate dehydrogenase → reduced pyrimidine synthesis in lymphocytes | Hepatotoxicity, hypertension, diarrhoea, marrow suppression, teratogenic with a very long half-life ( washout with colestyramine )
Rheumatology Anatomy Physiology Pharmacology - Leflunomide - RA and psoriatic arthritis; side effects - diarrhoea, hypertension , hepatotoxicity , weight loss, marrow suppression, peripheral neuropathy, pneumonitis. Very long half-life - teratogenic (men and women need a washout with colestyramine before conception).
Rheumatology: assessment, investigations and drugs - Leflunomide | Hypertension, liver, long half-life | Avoid - colestyramine washout
Rheumatology: assessment, investigations and drugs - First-line monotherapy - oral methotrexate , leflunomide or sulfasalazine (methotrexate is the usual choice).
Rheumatology: Inflammatory arthritis - Biologics and others - anti-TNF, rituximab, leflunomide, sulfasalazine.
Respiratory: Interstitial Lung Disease - Steroid-sparing: Methotrexate (most used), azathioprine, mycophenolate, leflunomide.
Respiratory: Interstitial Lung Disease - Methotrexate, mycophenolate, leflunomide, cyclophosphamide | Major malformations, miscarriage — stop before conception (methotrexate 3 months — check current advice; leflunomide washout)
Obstetrics - Methotrexate, mycophenolate , leflunomide | Malformations and miscarriage.
Obstetrics: Medical Problems
Where it is discussed in the book
- Respiratory: Interstitial Lung Disease (2 mentions)
- Obstetrics (1 mention)
- Obstetrics: Medical Problems (1 mention)
- Rheumatology Anatomy Physiology Pharmacology (1 mention)
- Rheumatology: assessment, investigations and drugs (3 mentions)
- Rheumatology: Inflammatory arthritis (2 mentions)
- Rheumatology: Emergencies, pregnancy and other systemic diseases (3 mentions)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (1 mention)
- Integrated respiratory chapter (2 mentions)
- Biochemistry: Metabolism of carbohydrates, lipids and proteins (1 mention)